📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Renovacor

1.1 - Company Overview

Renovacor Logo

Renovacor

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of preclinical-stage biopharmaceutical development of transformative gene therapy-based treatments for cardiovascular disease, featuring a lead recombinant adeno-associated virus (AAV) gene therapy program for patients with dilated cardiomyopathy.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Renovacor

Axovan Logo

Axovan

HQ: Switzerland Website
  • Description: Provider of drug development specializing in G protein-coupled receptors, based in Switzerland.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Axovan company profile →
AdjuCor Logo

AdjuCor

HQ: Germany Website
  • Description: Provider of reBEAT, a minimally invasive, epicardial, biventricular mechanical circulatory support device that assists one or both ventricles of the failing heart without blood contact; responsible for development, production, marketing, and selling of this technology for heart failure patients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AdjuCor company profile →
Bellerophon Therapeutics Logo

Bellerophon Therapeutics

HQ: United States Website
  • Description: Provider of innovative products that combine novel drugs and devices for the treatment of cardiopulmonary diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bellerophon Therapeutics company profile →
Xention Logo

Xention

HQ: United Kingdom Website
  • Description: Provider of ion channel-modulating drug discovery and development, offering therapeutics for atrial fibrillation, overactive bladder, pain, and autoimmune diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Xention company profile →
DalCor Pharmaceuticals Logo

DalCor Pharmaceuticals

HQ: Canada Website
  • Description: Provider of pharmacogenetic precision treatments for cardiovascular disease targeting patients with the ADCY9 AA genotype, including dalcetrapib; the completed Dal-GenE (DAL-301) cardiovascular outcomes trial; the Phase 3 Dal-GenE-2 (DAL-302) trial evaluating dalcetrapib’s potential to reduce fatal and non-fatal myocardial infarction; and the cobas ADCY9 genotype companion diagnostic developed with Roche Molecular Systems.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full DalCor Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Renovacor

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Renovacor

2.2 - Growth funds investing in similar companies to Renovacor

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Renovacor

4.2 - Public trading comparable groups for Renovacor

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Renovacor

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Renovacor

What does Renovacor do?

Renovacor is a provider of preclinical-stage biopharmaceutical development of transformative gene therapy-based treatments for cardiovascular disease, featuring a lead recombinant adeno-associated virus (AAV) gene therapy program for patients with dilated cardiomyopathy.

Who are Renovacor's competitors?

Renovacor's competitors and similar companies include Axovan, AdjuCor, Bellerophon Therapeutics, Xention, and DalCor Pharmaceuticals.

Where is Renovacor headquartered?

Renovacor is headquartered in United States.

How many employees does Renovacor have?

Renovacor has 1,000 employees 🔒.

When was Renovacor founded?

Renovacor was founded in 2010 🔒.

What sector and industry vertical is Renovacor in?

Renovacor is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Renovacor

Who are the top strategic acquirers in Renovacor's sector and industry

Top strategic M&A buyers and acquirers in Renovacor's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Renovacor?

Top strategic M&A buyers groups and sectors for Renovacor include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Renovacor's sector and industry vertical

Which are the top PE firms investing in Renovacor's sector and industry vertical?

Top PE firms investing in Renovacor's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Renovacor's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Renovacor's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Renovacor's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Renovacor include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Renovacor's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Renovacor?

The key public trading comparables and valuation benchmarks for Renovacor include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Renovacor for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Renovacor with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Renovacor's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Renovacor with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Renovacor's' sector and industry vertical?

Access recent funding rounds and capital raises in Renovacor's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Renovacor